Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warningnews2025-07-29T17:51:03+00:00July 29th, 2025|The New York Times|
Trump’s Tariffs on Medicines From Europe Stand to Cost Drugmakers Billionsnews2025-07-28T21:38:31+00:00July 28th, 2025|The New York Times|
UnitedHealth Grew to Be a Leviathan. Then Came the Backlash.news2025-07-28T14:47:45+00:00July 28th, 2025|The New York Times|
Couple Whose Home Was Bursting With Illegal Sex Pills Are Sentencednews2025-07-25T21:10:21+00:00July 25th, 2025|The New York Times|
U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDSnews2025-07-23T19:13:21+00:00July 23rd, 2025|The New York Times|
A Pill for Sleep Apnea Could Be on the Horizonnews2025-07-23T16:50:42+00:00July 23rd, 2025|The New York Times|
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threatnews2025-07-22T18:26:45+00:00July 22nd, 2025|The New York Times|
First Pill for Postpartum Depression Shows Varied Real-World Resultsnews2025-07-22T06:43:10+00:00July 22nd, 2025|The New York Times|
F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancynews2025-07-21T22:23:23+00:00July 21st, 2025|The New York Times|
Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidysnews2025-07-19T00:53:42+00:00July 19th, 2025|The New York Times|
